Nutex Health Inc.: stock overview

NUTXNASDAQTechnology · Services-Business Services, NEC

Price

$173.67

November 13, 2026Market cap $1.2B

DCF calculator

What Ploutos Investor adds for Nutex Health

Part of Ploutos Investor, €9.99 a month

See the plans
  • The full history: 16 fiscal years, from 2010
  • The estimated fair value, with its range and its certainty
  • The full analysis, 18 a month
  • More questions to the chat on its filings
  • Excel with every year
  • An email when it reports, changes its dividend or an officer buys

Sign in with a free account to see the last 5 fiscal years.

In short

Nutex Health had revenue of $797M over the last 12 months and net income of $165M, a net margin of 20.7%. Revenue grew by 26.1% a year on average over the last 5 years. At $173.67 the shares trade at a P/E of 7.4. It has net debt of $87M. It pays no dividend.

From its SEC filings (latest fiscal year to December 31, 2025) and the price of November 13, 2026.

Its SEC filings
Market cap
$1.2B
6.97M shares
P/E
7.4
Revenue, 12 months
$797M
+26.1% a year over 5 years
Net margin
20.7%
2025: 8.1%, above 68% of its industry

Worth knowing

What a holder would want to hear from the company's SEC filings of the last three years. Each with its filing, without comment.

3 fiscal years in figures

Each fiscal year's figures as the company filed them, and the share price at its end.

2023–2025 fiscal years

+88.0% a year over 2 years

  • 202510-K
    Revenue$875M
  • 202410-K
    Revenue$480M
  • 202310-K
    Revenue$248M

Fiscal years in figures

NUTX's revenue, profit, cash flow and dividend with each year-end price, from 2010 to 2022, 13 more fiscal years

Part of Ploutos Investor, €9.99 a month

See the plans

Sign in with a free account to see the last 5 fiscal years.

Key figures

The company's current figures in five groups. Each term is explained behind its ⓘ.

Valuation

Market cap 3-year median: $189M
$1.2B
Enterprise value 
$1.3B
P/E 
7.4
EV / EBIT 
4.2
EV / Revenue 
1.6
P/B 3-year median: 2.2
2.8
FCF yield 3-year median: 11.1%
20.5%
Earnings yield 3-year median: 6.4%
13.6%

Profitability

Gross margin 
47.8%
Operating margin 
39.0%
Net margin 3-year median: 8.1%
20.7%
ROIC 
61.1%
ROIC, 5-year average 
-16.8%
ROE 
45.2%

Growth

Revenue, yearly change 
+82.4%
EPS, yearly change 
+8.2%
FCF, yearly change 
+1,078.0%
Revenue, average a year 
+26.1%
EPS, average a year 
-17.2%

The yearly change compares FY2025 with FY2024.

Balance sheet

Cash 
$250M
Total debt 
$365M
Of which operating leases 
$28M
Net debt 
$87M
Net debt / EBITDA 
0.3x
Interest cover 
16.2x
Current ratio 
4.76

Balance sheet of September 30, 2026.

Returns to shareholders

Dividend yield 
0.00%
Buybacks 
0.41%
Total returned 
0.41%
Shares, yearly change 
+17.1%
Valuation against its own pastEach fiscal year's P/E, P/FCF and P/B beside today's, and the DCF calculator for the company.Valuation

Against its industry

Where its margins and returns stood in fiscal 2025 among the SEC filers of its industry (SIC code 73).

Gross margin

50.8%

Above 41% of the 293 companies in its industry, and 70% of all.

Operating margin

31.5%

Above 94% of the 462 companies in its industry, and 93% of all.

Net margin

8.1%

Above 68% of the 473 companies in its industry, and 61% of all.

ROE

21.5%

Above 81% of the 398 companies in its industry, and 85% of all.

ROA

7.7%

Above 78% of the 462 companies in its industry, and 82% of all.

Revenue growth

82.4%

Above 98% of the 461 companies in its industry, and 97% of all.

From the yearly figures every company files with the SEC, for those with revenue of at least $25 million. The industry is the first two digits of the SIC code.

The company at the SEC

How it is registered and when its fiscal year ends.

Name at the SEC
Nutex Health Inc.
CIK
1479681
Exchange
NASDAQ
Industry (SIC)
7389 · Services-Business Services, NEC
Fiscal year ends
December 31
Latest annual report
December 31, 2025
Reporting currency
USD
Shares
6.97M

Other companies: Technology

The largest companies of the same sector, each with its own page.

The Technology sectorAll companies

The full analysis

What do Nutex Health's filings show?

These are Nutex Health's figures. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.

  • A fair value range built from the filings
  • Earnings quality, debt and red flags
  • Insider and institutional moves
  • The case for and the case against

Questions about NUTX

Didn't find what you were looking for?

Ask us
What is NUTX's market cap?

Nutex Health Inc.'s market cap is $1.2B, at a price of $173.67 on November 13, 2026 and 6.97M shares.

What is NUTX's P/E?

NUTX's P/E is 7.4, on earnings per share of $23.22 over the last 12 months.

How much revenue does NUTX have?

Nutex Health had revenue of $797M over the last 12 months. Over the last 5 years it changed by +26.1% a year on average.

Does NUTX pay a dividend?

No. Nutex Health paid no regular dividend over the last 12 months.

Where do the figures come from?

From Nutex Health Inc.'s SEC filings (10-K and 10-Q) and the share price. They hold no analyst estimates and no score, and they are not a recommendation.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

US stocksThe market today, the sectors, the largest companies and the week's results.The market's sectorsThe 11 sectors side by side: returns, share of the market, median P/E and dividend.Compare stocksTwo companies side by side: price over up to ten years, with and without dividends, and every figure.US dividend stocksEach dividend's yield next to whether the company's cash covers it and whether it was ever cut.

The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.